
AI's Next Target in Pharma: The Decision Moment, Not the Doctor List
A Forbes Technology Council opinion piece argues that static HCP target lists are obsolete in pharma commercial strategy. Author Rahul Saluja proposes a dynamic, AI-driven 'living decision layer' focused on decision moments, continuous learning, and answering four key questions: What changed? Why now? What next? What did we learn? The article highlights shrinking HCP access and the need for timely, context-rich recommendations.
